{{Rsnum
|rsid=885814
|Gene=ALPL
|Chromosome=1
|position=21549423
|Orientation=plus
|GMAF=0.2603
|Gene_s=ALPL
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 52.2 | 40.7 | 7.1
| HCB | 46.7 | 42.3 | 10.9
| JPT | 56.6 | 40.7 | 2.7
| YRI | 76.2 | 23.8 | 0.0
| ASW | 61.4 | 33.3 | 5.3
| CHB | 46.7 | 42.3 | 10.9
| CHD | 54.6 | 37.0 | 8.3
| GIH | 34.7 | 41.6 | 23.8
| LWK | 81.8 | 16.4 | 1.8
| MEX | 27.6 | 58.6 | 13.8
| MKK | 85.3 | 13.5 | 1.3
| TSI | 56.9 | 37.3 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22569225
|Trait=None
|Title=Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNF&#x003b1; inhibitors in patients with rheumatoid arthritis.
|RiskAllele=
|Pval=0.000006
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}